Carisma Therapeutics
CARM
CARM
37 hedge funds and large institutions have $5.11M invested in Carisma Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 18 closing their positions.
Holders
37
Holders Change
-16
Holders Change %
-30.19%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
2
Increased
8
Reduced
13
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Barclays
London,
United Kingdom
|
$539K |
| 2 |
2
Renaissance Technologies
New York
|
$203K |
| 3 |
3
Two Sigma Investments
New York
|
$33.5K |
| 4 |
WC
4
Wexford Capital
West Palm Beach,
Florida
|
$34.2K |
| 5 |
5
Federated Hermes
Pittsburgh,
Pennsylvania
|
$4.88K |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
BlackRock
New York
|
$401K |
| 3 |
TGA
3
TPG GP A
Fort Worth,
Texas
|
$551K |
| 4 |
4
Jane Street
New York
|
$0 |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$74.1K |
